SMAD5 and pulmonary arterial hypertension: The identification of SMAD5 by this unbiased strategy has biological plausibility as SMAD5 encodes an intracellular transcriptional modulator that is activated by ligand binding of BMPR2, the most common genetic risk factor in heritable PAH (3).